HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 10 06 2020
accepted: 20 10 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 10 3 2021
Statut: epublish

Résumé

The atherogenic process begins already in childhood and progresses to symptomatic condition with age. We investigated the association of cholesterol efflux capacity (CEC) and vascular markers of subclinical atherosclerosis in healthy, young adults. CEC was determined in 2282 participants of the Young Finns study using cAMP treated

Identifiants

pubmed: 33154477
doi: 10.1038/s41598-020-76146-7
pii: 10.1038/s41598-020-76146-7
pmc: PMC7645719
doi:

Substances chimiques

Biomarkers 0
Cholesterol, HDL 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19223

Subventions

Organisme : Austrian Science Fund FWF
ID : P27116-B23 to AR
Pays : Austria
Organisme : European Research Council
ID : 742927 for MULTIEPIGEN project
Pays : International

Références

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1784-1793
pubmed: 27515591
Circ Res. 2014 Jan 3;114(1):171-82
pubmed: 24385510
N Engl J Med. 2011 Jan 13;364(2):127-35
pubmed: 21226578
J Am Coll Cardiol. 2008 Jul 22;52(4):293-9
pubmed: 18634985
Immunity. 2013 Apr 18;38(4):754-68
pubmed: 23477738
J Lipid Res. 2018 Apr;59(4):714-721
pubmed: 29436385
Eur Heart J. 2017 May 21;38(20):1597-1607
pubmed: 28379378
Atherosclerosis. 2016 Jun;249:116-24
pubmed: 27088866
N Engl J Med. 2015 May 7;372(19):1870-1
pubmed: 25946300
J Lipid Res. 2017 Apr;58(4):752-762
pubmed: 28167703
Circulation. 2002 Apr 2;105(13):1567-72
pubmed: 11927524
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4117-4123
pubmed: 28938424
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Circulation. 2004 Nov 2;110(18):2918-23
pubmed: 15505080
Transl Res. 2016 Jul;173:30-57
pubmed: 26972566
J Intern Med. 2004 Apr;255(4):457-68
pubmed: 15049880
Trends Endocrinol Metab. 2016 Jan;27(1):44-53
pubmed: 26673122
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):181-8
pubmed: 26543100
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13
pubmed: 26025389
Circ Res. 2004 Oct 15;95(8):764-72
pubmed: 15486323
N Engl J Med. 2014 Dec 18;371(25):2383-93
pubmed: 25404125
Circulation. 2005 Sep 6;112(10):1486-93
pubmed: 16129802
Nat Rev Cardiol. 2016 Jan;13(1):48-60
pubmed: 26323267
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2180-1
pubmed: 25231634
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Oct;1863(10):1257-1273
pubmed: 30305243
Am J Cardiol. 2016 Feb 15;117(4):508-514
pubmed: 26718234
Eur Heart J. 2015 Nov 14;36(43):3007-16
pubmed: 26248570
J Am Coll Cardiol. 2017 Jan 17;69(2):246-247
pubmed: 28081833
Eur J Clin Invest. 2014 Apr;44(4):395-401
pubmed: 24467215
Eur Heart J. 2005 Aug;26(16):1640-6
pubmed: 15932907
Front Pharmacol. 2015 Oct 05;6:218
pubmed: 26500551
Am J Clin Nutr. 2000 Nov;72(5 Suppl):1307S-1315S
pubmed: 11063473
JAMA. 2009 Sep 16;302(11):1210-7
pubmed: 19755700
Circulation. 1989 Jul;80(1):78-86
pubmed: 2610739
Atherosclerosis. 2012 Jun;222(2):390-4
pubmed: 22456230
Nephrol Dial Transplant. 2013 Oct;28(10):2456-63
pubmed: 23645475
J Cardiol. 2009 Jun;53(3):317-33
pubmed: 19477372
J Lipid Res. 2019 Aug;60(8):1457-1464
pubmed: 31142574
Circulation. 2010 Jan 5;121(1):110-22
pubmed: 20026785
Int J Mol Sci. 2018 Jul 06;19(7):
pubmed: 29986413
Circulation. 1995 Mar 1;91(5):1432-43
pubmed: 7867184
Hypertension. 2017 Aug;70(2):452-460
pubmed: 28652463
Eur Heart J. 2012 Sep;33(18):2307-16
pubmed: 22450427
JAMA. 2003 Nov 5;290(17):2277-83
pubmed: 14600186
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
Int J Epidemiol. 2008 Dec;37(6):1220-6
pubmed: 18263651

Auteurs

Monika Hunjadi (M)

Department of Internal Medicine I, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. monika.hunjadi@alumni.i-med.ac.at.

Claudia Lamina (C)

Division of Genetic Epidemiology, Medical University of Innsbruck, Innsbruck, Austria.

Patrick Kahler (P)

Department of Internal Medicine I, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.

Tamara Bernscherer (T)

Department of Internal Medicine I, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.

Jorma Viikari (J)

Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.

Terho Lehtimäki (T)

Department of Clinical Chemistry, Fimlab Laboratories and Finnish Cardiovascular Research Center-Tampere Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Mika Kähönen (M)

Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Mikko Hurme (M)

Department of Microbiology and Immunology, Faculty of Medicine and Health Technology, Tampere University and Pirkanmaa Hospital District, Tampere, Finland.

Markus Juonala (M)

Department of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.

Leena Taittonen (L)

Vaasa Central Hospital, Vaasa, Finland.

Tomi Laitinen (T)

Department of Clinical Physiology and Nuclear Medicine, Kuopio, University Hospital and University of Eastern Finland, Kuopio, Finland.

Eero Jokinen (E)

Department of Pediatric Cardiology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.

Päivi Tossavainen (P)

Department of Pediatrics, Oulu University Hospital, PEDEGO Research Unit and MRC Oulu, University of Oulu, Oulu, Finland.

Nina Hutri-Kähönen (N)

Department of Clinical Physiology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Olli Raitakari (O)

Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.

Andreas Ritsch (A)

Department of Internal Medicine I, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH